| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Clínica Baviera, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €27.40 |
| 52 Week High | €29.30 |
| 52 Week Low | €18.25 |
| Beta | 0.61 |
| 11 Month Change | -6.16% |
| 3 Month Change | -3.18% |
| 1 Year Change | 48.91% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 51.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0GWJ | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | -2.1% | -0.04% | 0.2% |
| 1Y | 48.9% | -25.3% | 7.4% |
Return vs Industry: 0GWJ exceeded the UK Healthcare industry which returned -23.2% over the past year.
Return vs Market: 0GWJ exceeded the UK Market which returned 8.3% over the past year.
Price Volatility
| 0GWJ volatility | |
|---|---|
| 0GWJ Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0GWJ has not had significant price volatility in the past 3 months.
Volatility Over Time: 0GWJ's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,254 | Eduardo Baviera Sabater | www.clinicabaviera.com |
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments.
Clínica Baviera, S.A. Fundamentals Summary
| 0GWJ fundamental statistics | |
|---|---|
| Market cap | €440.16m |
| Earnings (TTM) | €35.97m |
| Revenue (TTM) | €227.07m |
12.2x
P/E Ratio1.9x
P/S RatioIs 0GWJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0GWJ income statement (TTM) | |
|---|---|
| Revenue | €227.07m |
| Cost of Revenue | €115.10m |
| Gross Profit | €111.97m |
| Other Expenses | €76.00m |
| Earnings | €35.97m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.21 |
| Gross Margin | 49.31% |
| Net Profit Margin | 15.84% |
| Debt/Equity Ratio | 2.7% |
How did 0GWJ perform over the long term?
See historical performance and comparison